Abiopharma

🔍 Carroll Anthony (Executive)

Company: FTC Solar, Inc. (FTCI)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 400,000 shares of Common Stock (Direct)
  Date: 2026-05-04 | Code: A | equity_swap_involved: false | shares_owned_after: 434,205.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 200,000 shares of Common Stock (Direct)
  Date: 2026-05-04 | Code: A | equity_swap_involved: false | shares_owned_after: 634,205.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Reflects a grant of restricted stock units (RSUs) pursuant to an employment agreement and the Issuer's 2021 Stock Incentive Plan, and is subject to vesting as follows: (a) 200,000 of the RSUs (the "Three-Year Time-Based RSUs") vest over a three-year period, with 33.33% of the Three-Year Time-Based RSUs vesting on the one-year anniversary of the grant date, and 1/36 of such Three-Year Time-Based RSUs vesting at the end of each month for the next 24 months following the grant date; and (b) 200,000 of the RSUs (the "Four-Year Time-Based RSUs") vest over a four-year period, with 25% of such Four-Year Time-Based RSUs vesting on the one-year anniversary of the grant date, and 1/48 of such Four-Year Time-Based RSUs vesting at the end of each month for the next thirty-six months following the grant date.
• F2: Reflects a grant of performance based RSUs pursuant to an employment agreement and the Issuer's 2021 Stock Incentive Plan, and is subject to vesting, in whole or in part as further described in the employment agreement, upon (i) the Issuer's publicly traded common stock achieving a $10 and/or $20 price during the three year period from the grant date and (ii) the recipient's continued employment with the Issuer on any such date of achievement.